BioCentury
ARTICLE | Clinical News

Labopharm completes Phase III pain trial

June 11, 2003 7:00 AM UTC

Labopharm (TSE:DDS) completed enrollment of more than 1,000 patients with moderate to severe osteoarthritis pain in two double-blind U.S. Phase III trials of once-daily Tramadol. Tramadol, an opioid r...